Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

BMS temporarily withdraws Vanlev NDA

April 24, 2000

Teveten now available in the U.K. for the treatment of hypertension

April 24, 2000

ATP-sensitive K+ channel blockers reportedly useful for vagal nervous system dysfunction

April 24, 2000

CV Therapeutics develops sustained-release formulations of ranolazine

April 24, 2000

Flocor study results presented at sickle cell conference

April 20, 2000

News from FASEB: PST-2744 is a promising treatment for heart failure

April 18, 2000

U.S. academics discover potential gene therapy for restenosis

April 18, 2000

Potential antiatherogenic agent featured in two presentations at Experimental Biology

April 17, 2000

Opioid agonists for the prevention of myocardial ischemia

April 17, 2000

Novel method of controlling hypertension described at Experimental Biology

April 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...